Why isn’t insulin a complex generic? PA representative asks the FDA

16 July 2019 - Republican Mike Kelly (R-PA) sent a letter Tuesday to US FDA Acting Commissioner Ned Sharpless questioning ...

Read more →

China to soften generic drug buying program

15 July 2019 - Chinese drug makers jumped on Monday after a local news report that a centralised drug procurement ...

Read more →

FDA announces new efforts to expedite generic drug development and marketing to improve patient access to medicines

10 July 2019 - Today, the U.S. FDA announced a draft guidance, Harmonizing Compendial Standards With Drug Application Approval Using the ...

Read more →

Sneaky deals are keeping cheaper generic medicines off the market

27 June 2019 - It’s bad enough drug companies charge sky-high prices for brand-name prescription meds and raise those prices ...

Read more →

Epilepsy medicine worry

24 June 2019 - A controversial change of epilepsy drug funding could see her and thousands of other people with ...

Read more →

Atomoxetine – delay in change of funded brand and open access

19 June 2019 - PHARMAC is advising all interested parties that there will be a delay in the listing of ...

Read more →

FDA releases new data to help generic drug competitors

18 June 2019 - Generic drug applicants will now have more information from the US FDA when deciding whether to ...

Read more →

Statement on a new effort to improve transparency and predictability for generic drug applicants to help increase timely access to high-quality, lower cost generic drugs

18 June 2019 - The U.S. FDA is committed to helping facilitate American patients’ access to lower-cost generic medicines by ...

Read more →

As global markets for generic drugs fail, poor people pay the price

17 June 2019 - Healthy competition from generic drugs is often held up as a “cure” for high drug prices ...

Read more →

Realigning incentives to optimise generic and biosimilar prescribing

13 June 2019 - Drug prices and their impact on total US health care expenditures are again front of mind ...

Read more →

Prices of Canadian generic medicines below international average

29 May 2019 - PMRPB: Canadian price declines steepest of all OECD countries. ...

Read more →

Feilding woman nervous about PHARMAC's decision to change epilepsy medication brands

28 My 2019 - Judy Lawrence recalls vividly the day she suffered a seizure walking down the stairs eight years ...

Read more →

FDA's strengthened global inspection program helps ensure generic drug safety

17 May 2019 - Consumers must have confidence in the safety and quality of generic medicines.  ...

Read more →

Safety, efficacy, and quality remain top priorities as we continue our work to expand access to cost-saving generic drugs for the American public

13 May 2019 - Millions of Americans have difficulty paying for their prescription medications. ...

Read more →

Intellipharmaceutics announces FDA approval for generic Pristiq

10 May 2019 - Intellipharmaceutics announced today that it has received approval from the U.S. FDA for the Company's abbreviated new ...

Read more →